Metro Manila (CNN Philippines, August 29) — The Food and Drug Administration approved clinical trials for herbal medicine ‘lagundi’ as a supplement coronavirus treatment, Science and Technology Secretary Fortunato dela Peña announced Saturday.
De la Peña said in a briefing that participants will be around 200 COVID-19 patients with mild symptoms and admitted at the Quezon Institute quarantine center, Sta. Ana Hospital, and Philippine National Police-National Capital Region community quarantine center.
Experts from the Philippine General Hospital will lead the medical research.
“Ang hangad natin ay ma-address ang symptoms gaya ng ubo, lagnat at mga sore throat,” De la Peña said.
[Translation: We hope that lagundi could address symptoms such as cough, fever and sore throat.]
He added that the research will also try to find out if ‘lagundi’ may reduce severity of symptoms.
Other clinical trials
The FDA has yet to approve the studies which aim to look into